Zobrazeno 1 - 10
of 660
pro vyhledávání: '"vaccine introduction"'
Autor:
Pawan Kumar, Amanjot Kaur, Arindam Ray, Kapil Singh, Shipra Verma, Rhythm Hora, Seema S Koshal, Amrita Kumari, Rashmi Mehra, Syed F Quadri, Arup Deb Roy
Publikováno v:
Vaccine: X, Vol 19, Iss , Pp 100502- (2024)
Background and aims: The Rotavirus vaccine (RVV) introduction is a landmark event in the history of Indian public health as for the first time a novel, low-cost indigenous vaccine was introduced in a short timeline between 2016 and 2019. As per WHO m
Externí odkaz:
https://doaj.org/article/0cf04c3d7c4c4c7eae30ba85fc041fb1
Publikováno v:
Infectious Diseases of Poverty, Vol 13, Iss 1, Pp 1-5 (2024)
Abstract Background Immunization is a cornerstone of public health. Despite great success, China’s National Immunization Program (NIP) faces challenges, such as the integration of several World Health Organization-recommended vaccines and other sys
Externí odkaz:
https://doaj.org/article/4f6e9766459541698d91c7ba75891822
Autor:
Anithasree Athiyaman, Putri Herliana, Atiek Anartati, Niken Widyastuti, Prima Yosephine, Gertrudis Tandy, Sherli Karolina
Publikováno v:
Infectious Diseases of Poverty, Vol 12, Iss 1, Pp 1-5 (2023)
Abstract Despite high pneumococcal disease and economic burden in Indonesia and interest to introduce pneumococcal conjugate vaccine (PCV), there were challenges in establishing a comprehensive strategy to accelerate and enable the introduction in co
Externí odkaz:
https://doaj.org/article/e5c2ce7ee5674aca8c538ac460dde580
Autor:
Kurt Frey
Publikováno v:
Vaccines, Vol 12, Iss 7, p 811 (2024)
Rubella infection is typically mild or asymptomatic except when infection occurs during pregnancy. Infection in early pregnancy can cause miscarriage, stillbirth, or congenital rubella syndrome. Only individuals that are still susceptible to rubella
Externí odkaz:
https://doaj.org/article/5003b130ad0e42eebd817b6e5b66e06c
Autor:
Shalom Tchokfe Ndoula, Frank Mboussou, Andreas Ateke Njoh, Raoul Nembot, Simon Franky Baonga, Arnaud Njinkeu, Joseph Biey, Mohamed II Kaba, Adidja Amani, Bridget Farham, Jean-Christian Kouontchou Mimbe, Christian Armel Kouakam, Konstantin Volkmann, Crépin Hilaire Dadjo, Phanuel Habimana, Benido Impouma
Publikováno v:
Vaccines, Vol 12, Iss 4, p 346 (2024)
Cameroon introduced the malaria vaccine in its routine immunization program on 22 January 2024 in the 42 districts out of 200 that are among the most at risk of malaria. A cross-sectional analysis of the data on key vaccine events in the introduction
Externí odkaz:
https://doaj.org/article/520766690fd6497bb6a363f2de6b2533
Publikováno v:
Handbook of Applied Health Economics in Vaccines, 2023, ill.
Externí odkaz:
https://doi.org/10.1093/oso/9780192896087.003.0012
Publikováno v:
Vaccines, Vol 11, Iss 11, p 1722 (2023)
Significant progress has been made in vaccine development worldwide. This study examined the WHO African Region’s vaccine introduction trends from 2000 to 2022, excluding COVID-19 vaccines. We extracted data on vaccine introductions from the WHO/UN
Externí odkaz:
https://doaj.org/article/f3384800169a4bd598c2163e68e5397e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background In 2019, the RTS,S/AS01E malaria vaccine was introduced on a pilot basis in six regions of Ghana by the Ministry of Health/Ghana Health Service as part of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP). This i
Externí odkaz:
https://doaj.org/article/9e3387fb7a2e47f688126f20d70574df